Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06411132 · ClinicalTrials.gov registry record
Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
A clinical trial, sponsored by Dompé Farmaceutici S.p.A.
- Terminated
- Registry status
- 103
- Enrollment target
NCT06411132 is a clinical trial that was terminated before completion, run by Dompé Farmaceutici S.p.A. The registered enrollment target is 103 participants.
The verdict
NCT06411132 was terminated before completion, sponsored by Dompé Farmaceutici S.p.A.
- TERMINATED
- Registry status
- 103 participants
- Enrollment target
Study Summary
Primary Objective \- To assess the proportion of patients with Sjögren's dry eye who demonstrate impaired corneal sensitivity. Secondary Objectives * To assess corneal sensitivity via Cochet-Bonnet esthesiometer. * To assess tear secretion via Schirmer I test. * To assess Ocular Pain Assessment Survey (OPAS) questionnaire results.
Interventions
- OTHER observational study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2024-05-09 |
| Est. Completion | 2025-01-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06411132
The ClinicalTrials.gov registry entry for NCT06411132 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dompé Farmaceutici S.p.A, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which observational study is the first listed.
NCT06411132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06411132 about?
NCT06411132 is a clinical study titled "Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye". Primary Objective \- To assess the proportion of patients with Sjögren's dry eye who demonstrate impaired corneal sensitivity. Secondary Objectives * To assess corneal sensitivity via Cochet-Bonnet esthesiometer. * To assess tear secretion via Schirmer I test. * To assess Ocular Pain Assessment S...
What is the current status of trial NCT06411132?
This trial is currently terminated. The enrollment target is 103 participants. The study started on 2024-05-09. Estimated completion is 2025-01-10.
What interventions are being tested in trial NCT06411132?
The interventions under investigation include: observational study (OTHER).
Who is sponsoring clinical trial NCT06411132?
This trial is sponsored by Dompé Farmaceutici S.p.A, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.